NRIX Stock Price Forecast. Should You Buy NRIX?
Stock Details
NRIX 35
UBS Starts Nurix (NRIX) at Buy
David Dai·Thu Oct 24 2024
UBS
NRIX 30
Nurix (NRIX) PT Raised to $30 at H.C. Wainwright
Robert Burns·Mon Oct 21 2024
H.C. Wainwright
NRIX 35
Nurix Therapeutics price target raised to $35 from $30 at Oppenheimer
Matthew Biegler·Tue Oct 15 2024
Oppenheimer
NRIX 32
Wells Fargo Reiterates Overweight Rating on Nurix (NRIX)
Derek Archila·Tue Oct 15 2024
Wells Fargo
NRIX 34
Nurix (NRIX) PT Raised to $34 at Stifel
Stephen Willey·Mon Oct 14 2024
Stifel Nicolaus
NRIX 41
This Amazon Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Roger Song·Fri Oct 11 2024
Jefferies
NRIX 26
Nurix Therapeutics transferred with an Outperform at Baird
Brian Skorney·Thu Sep 05 2024
Robert W. Baird
NRIX 27
Nurix (NRIX) PT Raised to $27 at Oppenheimer
Matthew Biegler·Wed Aug 14 2024
Oppenheimer
NRIX 26
Nurix (NRIX) PT Raised to $26 at RBC Capital
Gregory Renza·Thu Jun 27 2024
RBC Capital
NRIX 26
Nurix (NRIX) PT Raised to $26 at H.C. Wainwright
Robert Burns·Tue Jun 18 2024
H.C. Wainwright
NRIX 35
Piper Sandler Reiterates Overweight Rating on Nurix (NRIX)
Tyler Van Buren·Wed Jun 05 2024
Piper Sandler
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow